Moneycontrol
HomeNewscoronavirusCOVID-19 | Delhi High Court pulls up Centre over oxygen shortage: Key highlights

COVID-19 | Delhi High Court pulls up Centre over oxygen shortage: Key highlights

The High Court also directed the central government to show cause as to why contempt not be initiated against it for failing to comply with order on supply of oxygen to Delhi.

May 04, 2021 / 22:48 IST
Story continues below Advertisement
The bench rejected the Centre's submission which said Delhi was not entitled to 700 metric tonnes of medical oxygen in light of existing medical infrastructure.

The Delhi High Court on May 4 ordered the Union government to supply 700 MT oxygen daily to Delhi "right away by whatever means."

"There's SC order, now we also say the Centre will have to supply 700 MT oxygen daily to Delhi right away by whatever means," Bar and Bench quoted the Delhi High Court order.

Story continues below Advertisement

Apart from this, the bench of justices -- comprising Vipin Sanghi and Rekha Palli -- directed the Centre to show cause on why contempt of court should not be initiated for non-compliance of orders, which was passed with respect to the oxygen supply in Delhi and NCR.

COVID-19 Crisis | Supreme Court comes down hard on Centre: Key highlights

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show